September 27th, 2022

The Ozempic Shortage Explained

Ozempic, manufactured by Novo Nordisk, is a medication FDA approved for treatment of type 2 diabetes. An uptick in off-label prescription use, for indications such as Obesity, has led to an increase in demand for Ozempic. The high demand has resulted in an Ozempic shortage nationwide. The manufacturer has indicated the shortage will continue until December 2022. 

Social media platform, TikTok, has also seen an uptick in hashtags and views related to Ozempic. As of September 2022, #Ozempic has 185.6 million views and the hashtag #OzempicWeightLoss with 69.9 million views. 

It’s important our members continue to manage their blood glucose levels to prevent long term complications from diabetes. SmithRx is available to support our members and clients in navigating the short supply. We have sent mailers to potentially impacted members and provided covered, formulary alternatives and proactive measures to ensure members have enough medication on hand.

Other Recent Posts

Is there a “Twindemic” upon us?

As the world battled the COVID-19 pandemic in 2020 and 2021, with heightened measures to quarantine and social distance, the influenza virus remained relatively inactive and maintained a low profile. However, the 2022 seasonal influenza virus may be rebounding in higher numbers than anticipated. Influenza, the “flu,” is a contagious respiratory disease and spreads mainly… Continue reading Is there a “Twindemic” upon us?

The end of an era.

Humira price hikes come to an end with biosimilars in 2023. After nearly two decades of patent exclusivity and $200 billion in sales, Abbvie’s monopoly on Humira (adalimumab) is ending in 2023. What does this mean for members and employer groups now that the highest grossing drug of all time finally has competition from biosimilar… Continue reading The end of an era.

The Ozempic Shortage Explained

Ozempic, manufactured by Novo Nordisk, is a medication FDA approved for treatment of type 2 diabetes. An uptick in off-label prescription use, for indications such as Obesity, has led to an increase in demand for Ozempic. The high demand has resulted in an Ozempic shortage nationwide. The manufacturer has indicated the shortage will continue until… Continue reading The Ozempic Shortage Explained

Partnering with SmithRx to provide transparent pharmacy benefits helps us deliver low-cost, high-quality care. Their pass-through model is the best way to ensure prescription drug pricing is fair.

Will Young
CEO at Sana Benefits

My loudest and most challenging group was handled perfectly in the first 30 days post-go-live by SmithRx. If it were up to me, I would put every one of my new groups with SmithRx.

Ken Mensio
Vice President at Risk Strategies

Ready to make the leap?

Ready to make the leap?

99%+

client retention

1,200+

employers served

50%

potential RX savings